Patent · US Active

Composite formulation comprising a tablet encapsulated in a hard capsule

US9220704B2 · kind B2 · utility

6Cited by
6References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 15, 2012
Grant dateDec 29, 2015
Priority date
Expiry dateOct 15, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/616
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a hard capsule composite formulation comprising a capsule having a hemispherical closure at each end and an interior space; and one or more tablets encapsulated in the capsule, wherein the tablet or the tablets as a whole have a shape conforming to the internal space of the capsule. The hard capsule composite formulation can efficiently charge pharmaceutical compositions inside the limited interior space of the capsule, and hence, it allows packing a high-dose of pharmaceutical composition in a relatively small-sized capsule, which increases productivity and patient compliance. Also, the composite formulation exhibits good dissolution rate because pharmaceutically active ingredients contained in the capsule are separated from one another, and thus, the ingredients are less affected by the dissolution rate of one another, allowing good storage stability which can optimize the therapeutic effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.